A fixed-dose 24-hour regimen of artesunate plus sulfamethoxypyrazine-pyrimethamine for the treatment of uncomplicated <it>Plasmodium falciparum </it>malaria in eastern Sudan

by Osman Maha E, Khalil Insaf F, Magzoub Mamoun, Adam Ishag, Alifrangis Michael, Elmardi Khalid A
Published 2006-08-01

Development of ELISA-based methods to measure the anti-malarial drug chloroquine in plasma and in pharmaceutical formulations

by Ronn Anita, Bygbjerg Ib C, Recke Camilla, Hoegberg Lotte C, Alifrangis Michael, Khalil Insaf F, Koch Claus
Published 2011-08-01

The implication of <it>dihydrofolate reductase </it>and <it>dihydropteroate synthetase </it>gene mutations in modification of <it>Plasmodium falciparum </it>characteristics

by Elbashir Mustafa I, Masuadi Emad M, Bygbjerg Ib C, Khalil Insaf F, Alifrangis Michael, A-Elbasit Ishraga E, Giha Hayder A
Published 2007-08-01